S. 296 was introduced in the 112th Congress, which has adjourned.

It has not yet been reintroduced.

You can increase the chances that the bill is revived in the new Congress by showing support for reintroduction.

Want to be notified when this bill is reintroduced?

View S. 296 (112th) report

What’s your position on S. 296 (112th)?

S. 296: Preserving Access to Life-Saving Medications Act

Summary: A bill to amend the Federal Food, Drug, and Cosmetic Act to provide the Food and Drug Administration with improved capacity to prevent drug shortages. (More Info)

S. 296 was introduced in the 112th Congress, which has adjourned. It has not yet been reintroduced.

What POPVOX Users Say

POPVOX Nation:
86% Support
13% Oppose
(89 users)

View Report & Comments

77 users
12 users
order determined by social media popularity

Endorsing Organizations

American Society of Health-System Pharmacists 20,774 Facebook fans 5,842 Twitter followers

ASHP supports the Preserving Access to Life Saving Medications Act (S. 296) cosponsored by Sens. Klobuchar and Casey. Drug shortages in hospitals and health systems cause significant disruptions in patient care. The medications affected are often life saving drugs as well as medications used to relieve pain, to treat serious infections, and other conditions.

http://www.ashp.org/congress

Read full position statement.

* This organization’s position on this bill was entered by POPVOX.

Michigan Pharmacists Association 1,704 Facebook fans 1,437 Twitter followers

Senate Bill 296 would provide the U.S. Food and Drug Administration (FDA) with tools to better manage and hopefully prevent shortages of life-saving medications. This legislation enables the FDA to work more effectively with the pharmaceutical supply chain to ensure drug availability, and enhances the agency's ability to monitor drugs that are vulnerable to shortages in the future. The legislation also enables FDA to work with drug manufacturers to establish contingency plans for manufacturing interruptions, such as raw material shortages, adjustments to production capabilities and product discontinuations.

http://www.michigan...ocacy/actionCenter/

Read full position statement.

* This organization’s position on this bill was entered by POPVOX.